Answers are grounded in this paper and cite their sources.
lack of resistance. With an increasing array of new agents becoming available, paediatricians will have to continually re-evaluate antibiotic policies as patterns of microbial resistance change and new drugs enter clinical use. It is unlikely however that new antibiotics alone will significantly alter the mortality and morbidity associated with bacterial meningitis. The advent of effective vaccines and new therapeutic interventions to modulate the damaging host inflammatory response to invading micro-organisms should ultimately improve the outcome of bacterial meningitis in the future.
No takes yet. Share an insight, caveat, or question.
Klein et al. (1992) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: